文献速递认知障碍与痴呆帕金森病与运动障碍

伴嗅觉减退但无运动障碍的早期神经元突触核蛋白病认知表现

Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder.
PubMed 文献 · Ann Neurol · 2025-07-11

本研究基于PPMI基线数据,用认知综合评分评估伴嗅觉减退但无运动障碍的早期NSD患者(2A期101例、2B期227例)及健康对照158例。结果示2B期认知显著差于对照,2A期仅合并iRBD者认知显著变差;提示多巴胺缺乏和iRBD影响早期NSD认知。

要点

  • 2B期患者认知综合评分显著低于健康对照,效应量0.40。
  • 2A期单纯嗅觉减退认知正常,合并iRBD者认知显著变差。
  • 2B期嗅觉减退者认知已异常,叠加iRBD有显著附加效应。

核心结论

  • 伴嗅觉减退但无运动障碍的早期NSD患者中,嗅觉减退与认知缺陷相关,尤其合并多巴胺系统损害或iRBD时。

研究设计与样本

  • 基于PPMI基线数据的横断面研究,纳入NSD-ISS 2A期101例、2B期227例及健康对照158例。

主要发现

  • 2B期认知综合评分较健康对照差(z分数均值差0.23,p<0.05,效应量0.40)。
  • 2A期整体认知与对照无显著差异(z分数均值差0.05,p=NS,效应量0.09)。
  • 2A期合并iRBD者认知显著差于对照(z分数均值差0.33,p<0.05,效应量0.50)。
  • 2B期单纯嗅觉减退者认知异常(z分数均值差0.18,p=0.0078,效应量0.29),叠加iRBD有显著附加效应。

临床怎么用

  • 在突触核蛋白病各阶段均应评估认知,即使尚无运动障碍。
  • 对伴嗅觉减退的早期NSD患者,需关注多巴胺缺乏和iRBD对认知的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the impact of dopamine deficiency and isolated rapid eye movement (REM) sleep behavior disorder (iRBD) on cognitive performance in early neuronal α-synuclein disease (NSD) with hyposmia but without motor disability. METHODS: Using Parkinson's Progression Markers Initiative baseline data, cognitive performance was assessed with a cognitive summary score (CSS) derived from robust healthy control (HC) norms. Performance was examined for participants with hyposmia in early NSD-Integrated Staging System (NSD-ISS), either stage 2A (cerebrospinal fluid α-synuclein seed amplification assay [SAA]+, dopamine transporter scan [DaTscan]-) or 2B (SAA+, DaTscan+). RESULTS: Participants were stage 2A (n = 101), stage 2B (N = 227), and HCs (n = 158). Although stage 2 had intact Montreal Cognitive Assessment scores (mean [SD] = 27.0 [2.3]), stage 2A had a numerically worse CSS (z-score mean difference = 0.05, p = NS; effect size = 0.09) and stage 2B a statistically worse CSS (z-score mean difference = 0.23, p < 0.05; effect size = 0.40) compared with HCs. In stage 2A, hyposmia alone was associated with normal cognition, but those with comorbid iRBD had significantly worse cognition (z-score mean difference = 0.33, p < 0.05, effect size =0.50). In stage 2B, hyposmia alone had abnormal cognition (z-score mean difference = 0.18, p = 0.0078, effect size = 0.29), and superimposed iRBD had a statistically significant additive effect. INTERPRETATION: Using a novel CSS, we demonstrated that hyposmia is associated with cognitive deficits in prodromal NSD without motor disability, particularly when comorbid dopamine system impairment or comorbid iRBD is present. Therefore, it is critical to include and assess cognition at all stages when studying synuclein disease, even in the absence of motor disability. ANN NEUROL 2025;98:482-491.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Weintraub D, Nair AR, Kurth R, et al. Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2025. PMID: 40641332. doi:10.1002/ana.27263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。